ACAD
28.01
+0.16
+0.57%
AEMD
2.06
+0.01
+0.49%
APRI
1.04
+0.01
+0.97%
ARNA
1.34
+0.01
+0.75%
ATEC
2.09
+0.02
+0.97%
CNAT
5.3
+0.08
+1.53%
CRXM
0.121
-0.049
-28.824%
CYTX
0.96
-0.01
-1.03%
DXCM
68.85
+1.19
+1.76%
GNMK
13.21
+0.2
+1.54%
HALO
12.79
-0.12
-0.93%
ILMN
174.92
-2.09
-1.18%
INNV
0.108
+0.01
+9.6939%
INO
7.09
-0.08
-1.12%
ISCO
1.64
-0.09
-5.20%
ISIS
57.56
0.00
0.00%
LGND
113.44
-0.37
-0.33%
LPTN
2.93
0.00
0.00%
MBVX
1.71
-0.09
-5.00%
MEIP
1.64
+0.02
+1.23%
MNOV
5.65
+0.14
+2.54%
MRTX
3.65
0.00
0.00%
MSTX
0.131
0.00
0.00%
NBIX
53.64
+0.85
+1.61%
NUVA
71.54
+0.66
+0.93%
ONCS
0.9
-0.05
-5.14%
ONVO
2.81
+0.02
+0.72%
OREX
3.03
-0.12
-3.81%
OTIC
13.25
-0.15
-1.12%
QDEL
24.57
+0.16
+0.66%
RCPT
231.96
0.00
0.00%
RGLS
1.375
-0.075
-5.172%
RMD
69.51
+1.11
+1.62%
SCIE
0.001
0.00
0.00%
SPHS
2.48
-0.01
-0.40%
SRNE
1.725
+0.15
+9.524%
TROV
0.776
-0.025
-3.121%
VICL
2.29
+0.02
+0.88%
VOLC
18
0.00
0.00%
ZGNX
13.1
-0.25
-1.87%
ACAD
28.01
+0.16
+0.57%
AEMD
2.06
+0.01
+0.49%
APRI
1.04
+0.01
+0.97%
ARNA
1.34
+0.01
+0.75%
ATEC
2.09
+0.02
+0.97%
CNAT
5.3
+0.08
+1.53%
CRXM
0.121
-0.049
-28.824%
CYTX
0.96
-0.01
-1.03%
DXCM
68.85
+1.19
+1.76%
GNMK
13.21
+0.2
+1.54%
HALO
12.79
-0.12
-0.93%
ILMN
174.92
-2.09
-1.18%
INNV
0.108
+0.01
+9.6939%
INO
7.09
-0.08
-1.12%
ISCO
1.64
-0.09
-5.20%
ISIS
57.56
0.00
0.00%
LGND
113.44
-0.37
-0.33%
LPTN
2.93
0.00
0.00%
MBVX
1.71
-0.09
-5.00%
MEIP
1.64
+0.02
+1.23%
MNOV
5.65
+0.14
+2.54%
MRTX
3.65
0.00
0.00%
MSTX
0.131
0.00
0.00%
NBIX
53.64
+0.85
+1.61%
NUVA
71.54
+0.66
+0.93%
ONCS
0.9
-0.05
-5.14%
ONVO
2.81
+0.02
+0.72%
OREX
3.03
-0.12
-3.81%
OTIC
13.25
-0.15
-1.12%
QDEL
24.57
+0.16
+0.66%
RCPT
231.96
0.00
0.00%
RGLS
1.375
-0.075
-5.172%
RMD
69.51
+1.11
+1.62%
SCIE
0.001
0.00
0.00%
SPHS
2.48
-0.01
-0.40%
SRNE
1.725
+0.15
+9.524%
TROV
0.776
-0.025
-3.121%
VICL
2.29
+0.02
+0.88%
VOLC
18
0.00
0.00%
ZGNX
13.1
-0.25
-1.87%
Home » Archive by Category

Xconomy

Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More

March 31, 2017 – 2:45 am

As far as singular weeks go for biotech, this was a big one. Three highly anticipated drugs were approved. One is the first injectable medication for eczema. Another might help fend off the…

[[Click headline to continue reading.]]

Echo Raises $7.5M to Meet Big Orders for Hybrid Digital Microscope

March 30, 2017 – 12:56 pm

Echo, a San Diego startup that has developed a digital, all-in-one microscope, says today it has closed on $7.5 million in a Series A round led by San Francisco-based Dolby Family Ventures and…

[[Click headline to continue reading.]]

Mary Lou Jepsen, Moonshots, and the Human Impact of Innovation

March 29, 2017 – 7:19 am

As expressions go, “moonshot” has recently been gaining a lot of popularity in the media vernacular. Many folks assume that it arose with NASA’s Apollo 11 mission to the moon. But it’s a matter of…

[[Click headline to continue reading.]]

ViaCyte Working with Gore to Improve its Synthetic Pancreas Device

March 29, 2017 – 5:00 am

San Diego-based ViaCyte said today it is collaborating with W.L. Gore & Associates, the privately held company that makes Gore-Tex fabrics, medical devices, and other products, in a bid to…

[[Click headline to continue reading.]]

Ionis Pharma Spins Out Lipid Disorder Unit Akcea with Plans for IPO

March 27, 2017 – 7:35 am

Akcea Therapeutics, an Ionis Pharmaceuticals subsidiary focused on rare lipid disorders, is spinning out of its parent with plans for an initial public stock offering as it prepares to file for FDA…

[[Click headline to continue reading.]]

Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC

March 24, 2017 – 3:25 am

Who knew healthcare could be so complicated? This week, President Trump and the GOP saw first hand, as a feverish rally to get their healthcare bill through the House of Representatives on Thursday…

[[Click headline to continue reading.]]

Today Only: Save $70 for Human Impact of Innovation on April 19th

March 23, 2017 – 2:45 am

Xconomy is convening life sciences and technology founders, executives, investors, and entrepreneurs for an afternoon of fireside chats and solo talks at Human Impact of Innovation. A few topics…

[[Click headline to continue reading.]]

Amid Gender Gap Talk, Mentor Network Emerges For Women In Health, Bio

March 23, 2017 – 2:30 am

It’s been more than a year since an infamous party with hired models in cocktail dresses captured the biotech community’s attention at the 2016 J.P. Morgan conference. There has been…

[[Click headline to continue reading.]]

Join David Baltimore, Nicole Glaros, Nathan Myhrvold, & More at Our Napa Summit

March 22, 2017 – 3:15 am

Year after year, Xconomy has gathered exemplary business leaders, investors, and far-seeing technologists to our most prestigious event—The Napa Summit. This year is no different. Come join us…

[[Click headline to continue reading.]]

Waving White Flag, Cerulean Merges With Dare Bio, Sells Cancer Drugs

March 20, 2017 – 6:41 am

Cerulean Pharma may have been able to survive one brush with death, but the second has proven fatal. Today, the Waltham, MA, company announced plans to merge with a privately held women’s health…

[[Click headline to continue reading.]]